SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001424884-15-000039
Filing Date
2015-04-15
Accepted
2015-04-15 16:02:33
Documents
10
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1080637
2 form10-k0.jpg GRAPHIC 33280
3 exhibit31-1.htm EX-31.1 14141
4 exhibit32-1.htm EX-32.1 5288
  Complete submission text file 0001424884-15-000039.txt   5186707

Data Files

Seq Description Document Type Size
5 tpiv-20141231.xml EX-101.INS 581260
6 tpiv-20141231.xsd EX-101.SCH 49718
7 tpiv-20141231_cal.xml EX-101.CAL 45253
8 tpiv-20141231_def.xml EX-101.DEF 136727
9 tpiv-20141231_lab.xml EX-101.LAB 330085
10 tpiv-20141231_pre.xml EX-101.PRE 237006
Mailing Address 1551 EASTLAKE AVENUE EAST, SUITE 100 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST, SUITE 100 SEATTLE WA 98102 (206) 504-7278
TAPIMMUNE INC (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 0220
Type: 10-K | Act: 34 | File No.: 000-27239 | Film No.: 15771718
SIC: 2834 Pharmaceutical Preparations